BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 23487343)

  • 21. Hyperfibrinolysis resulting from clotting activation in patients with different degrees of cirrhosis. The CALC Group. Coagulation Abnormalities in Liver Cirrhosis.
    Violi F; Ferro D; Basili S; Quintarelli C; Musca A; Cordova C; Balsano F
    Hepatology; 1993 Jan; 17(1):78-83. PubMed ID: 8423044
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The coagulation system in patients with end-stage liver disease.
    Valla DC; Rautou PE
    Liver Int; 2015 Jan; 35 Suppl 1():139-44. PubMed ID: 25529099
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The coagulopathy of chronic liver disease: is there a causal relationship with bleeding? No.
    Tripodi A
    Eur J Intern Med; 2010 Apr; 21(2):65-9. PubMed ID: 20206872
    [No Abstract]   [Full Text] [Related]  

  • 24. Association between low-grade disseminated intravascular coagulation and endotoxemia in patients with liver cirrhosis.
    Violi F; Ferro D; Basili S; Saliola M; Quintarelli C; Alessandri C; Cordova C
    Gastroenterology; 1995 Aug; 109(2):531-9. PubMed ID: 7615203
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hemostasis and global fibrinolytic capacity in chronic liver disease.
    Aytac S; Turkay C; Bavbek N; Kosar A
    Blood Coagul Fibrinolysis; 2007 Oct; 18(7):623-6. PubMed ID: 17890949
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Coagulopathy in liver disease: Lack of an assessment tool.
    Blasi A
    World J Gastroenterol; 2015 Sep; 21(35):10062-71. PubMed ID: 26401071
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence for an enhanced fibrinolytic capacity in cirrhosis as measured with two different global fibrinolysis tests.
    Rijken DC; Kock EL; Guimarães AH; Talens S; Darwish Murad S; Janssen HL; Leebeek FW
    J Thromb Haemost; 2012 Oct; 10(10):2116-22. PubMed ID: 22906184
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical application of fibrinolysis laboratory tests: a review.
    Prisco D; Conti AA; Giurlani L; Falciani M
    Ann Ital Med Int; 1998; 13(2):81-7. PubMed ID: 9734140
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coagulopathy in cirrhosis - the role of the platelet in hemostasis.
    Tapper EB; Robson SC; Malik R
    J Hepatol; 2013 Oct; 59(4):889-90. PubMed ID: 23669288
    [No Abstract]   [Full Text] [Related]  

  • 30. Interrelation between factor VII, prekallikrein, and hyperfibrinolysis in advanced cirrhosis.
    Violi F; Alessandri C; Ferro D; Saliola M; Cordova C; Musca A; Balsano F
    J Clin Pathol; 1989 Dec; 42(12):1246-9. PubMed ID: 2613916
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of coagulation and fibrinolysis in children with chronic liver disease.
    El-Sayed R; El-Karaksy H; El-Raziky M; El-Hawary M; El Koofy N; Helmy H; Fahmy M
    Blood Coagul Fibrinolysis; 2013 Mar; 24(2):113-7. PubMed ID: 23314384
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Massive bleeding due to hyperfibrinolysis during living-related liver transplantation for terminal liver cirrhosis; report of two cases].
    Kaku R; Matsumi M; Ichiyama M; Kajihara H; Fujii H; Ohashi I; Mizobuchi S; Morita K
    Masui; 2003 Nov; 52(11):1195-9. PubMed ID: 14661565
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The efficacy and safety of epsilon-aminocaproic acid treatment in patients with cirrhosis and hyperfibrinolysis.
    Gunawan B; Runyon B
    Aliment Pharmacol Ther; 2006 Jan; 23(1):115-20. PubMed ID: 16393288
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changing Concepts of Cirrhotic Coagulopathy.
    Tripodi A; Primignani M; Mannucci PM; Caldwell SH
    Am J Gastroenterol; 2017 Feb; 112(2):274-281. PubMed ID: 27801884
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Studies on the mechanism of hyperfibrinolysis in liver cirrhosis--changes of plasma t-PA, PAI-1 and active PAI-1 levels in liver cirrhosis].
    Matsuura R; Soma M; Maeda Y; Kasakura S
    Rinsho Byori; 1995 Dec; 43(12):1256-60. PubMed ID: 8569037
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thrombin generation: what have we learned?
    Al Dieri R; de Laat B; Hemker HC
    Blood Rev; 2012 Sep; 26(5):197-203. PubMed ID: 22762893
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ongoing prothrombotic state in the portal circulation of cirrhotic patients.
    Violi F; Ferro D; Basili S; Lionetti R; Rossi E; Merli M; Riggio O; Bezzi M; Capocaccia L
    Thromb Haemost; 1997 Jan; 77(1):44-7. PubMed ID: 9031447
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Perioperative monitoring of primary and secondary hemostasis in coronary artery bypass grafting.
    Hertfelder HJ; Bös M; Weber D; Winkler K; Hanfland P; Preusse CJ
    Semin Thromb Hemost; 2005; 31(4):426-40. PubMed ID: 16149021
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Liver cirrhosis--procoagulant stasis].
    Prelipcean CC; Fierbinteanu-Braticevici C; Drug VL; Lăcătuşu C; Mihai B; Mihai C
    Rev Med Chir Soc Med Nat Iasi; 2011; 115(3):678-85. PubMed ID: 22046771
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diurnal changes of fibrinolysis in patients with liver cirrhosis and esophageal varices.
    Piscaglia F; Siringo S; Hermida RC; Legnani C; Valgimigli M; Donati G; Palareti G; Gramantieri L; Gaiani S; Burroughs AK; Bolondi L
    Hepatology; 2000 Feb; 31(2):349-57. PubMed ID: 10655257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.